 |
|
|
| |
No Relevant Difference in Incident Hypertension Observed by Gender, Race, Baseline BMI, or Other Key Subgroups Through Week 96 Among People Living With HIV-1 (PLWH) Receiving Dolutegravir (DTG)-Based Regimens or Comparator Antiretroviral Therapy (cART) in Pooled Randomized Clinical Trials
|
| |
| |
Parul Patel1, Ana Milinkovic2, Richard Grove3, Lindsay Govan3, Michael McKenna3, V. Paul DiMondi1, Cassidy Henegar1, Brian Wynne1, Nassrin Payvandi2, Bryn Jones2
1ViiV Healthcare, Durham, NC, United States; 2ViiV Healthcare, Brentford, United Kingdom; 3GSK, Brentford, United Kingdom
|
| |
|
|
|
|
|
